Articles tagged “weight loss”
2 articles
What Is Retatrutide? Mechanism, Uses, Risks, and FDA Status
An evidence-based overview of Retatrutide — a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously, showing unprecedented weight loss results in Phase II clinical trials.
May 8, 20265 min readguide
Semaglutide vs Tirzepatide vs Retatrutide: A Data-Driven Comparison
Three generations of incretin-based therapy — one approved in 2017, one in 2022, one still in trials. Here's how they compare on efficacy, mechanism, side effects, and what the data actually shows.
April 21, 20266 min readguide
All Tags
503A503BAOD-9604BDNFBPC-157BremelanotideCJC-1295COACategory 1Category 2DihexaEgriftaEmideltideEpitalonEpithalonFDAFSAGHK-CuGHRHGIPGLP-1HPLCHSAHims & HersIpamorelinJuly 2026KPVLL-37MOTS-cMOTs-cMedicareMounjaroOzempicPCACPT-141RetatrutideRussiaSelankSemaxTB-500TesamorelinThymosin Alpha-1agingalpha-MSHanalysisanalytical chemistryangiotensin IVanti-aginganti-inflammatoryantimicrobial peptideanxiolyticbacteriostatic waterbeginnerbeginner guidebiohackingbloodworkbudgetcathelicidinclinicclinicscognitivecognitive enhancementcomparisoncompetitioncompoundingcompounding pharmacyconsultationcostcoveragedatadosingeconomicsexercisefakefertilityfinding a doctorfunctional medicineglucagongrowth hormonegut healthhealinghistoryhormoneshow toinjectioninnate immunityinsulin sensitivityinsuranceipamorelinlegallegal risklegitimatelipodystrophymarketmelanocortinmenopausemetabolismmitochondriamitochondrial peptideneuroprotectionnootropicpatient advocacypeptide guidepeptide protocolspharmaceutical-gradepharmacyphysicianpineal glandpricingprior authorizationprotocolspublic commentpurityqualityreclassificationreconstitutionrecoveryred flagsregulationregulatoryresearchretatrutidesafetysemaglutidesermorelinsexual dysfunctionside effectsstackingstoragetelehealthtelomerasetirzepatidetriple agonisttuftsinvaluevendor verificationvisceral fatweight losswhat iswomen